Where does Glaxosmithkline Consumer Healthcare (UK) IP Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Glaxosmithkline Consumer Healthcare (UK) IP Limited ranks #13,446 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Glaxosmithkline Consumer Healthcare (UK) IP Limited's Innovation Score?

Glaxosmithkline Consumer Healthcare (UK) IP Limited has an Innovation Score of 33.5 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Glaxosmithkline Consumer Healthcare (UK) IP Limited focus on?

Glaxosmithkline Consumer Healthcare (UK) IP Limited's top technology area is A46B (Brushes) with 8 patents, ranking #34 of 322 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Glaxosmithkline Consumer Healthcare (UK) IP Limited's patent grant rate increasing or decreasing?

Glaxosmithkline Consumer Healthcare (UK) IP Limited's recent grant velocity is +167% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Glaxosmithkline Consumer Healthcare (UK) IP Limited's patents?

Glaxosmithkline Consumer Healthcare (UK) IP Limited's patents average 8.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Glaxosmithkline Consumer Healthcare (UK) IP Limited

Q: How many patents does Glaxosmithkline Consumer Healthcare (UK) IP Limited hold?

Glaxosmithkline Consumer Healthcare (UK) IP Limited holds 22 US utility patents granted between 2017 and 2024, spanning 14 technology areas.

Q: How is the Glaxosmithkline Consumer Healthcare (UK) IP Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 22 granted patents across 14 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A46B (Brushes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glaxosmithkline ranks #13,446 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 14 technology areas.

#13,446
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.5/100): 8.6
avg claims per patent: +167%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13446 · Foreign Corporation #13,446 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,446/49,997
PHOTO-FINISH Galera Labs
CPC-FOCUS A46B · 14 areas
INNOV-THIN 33.5/100
CLAIMS-PAR 8.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +167% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Galera Labs, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glaxosmithkline’s 33.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (32%) Velocity 4.2 pts (13%) Breadth 13.2 pts (40%) Claim depth 5.2 pts (16%)

Qualcomm Incorporated · highest

85
Glaxosmithkline… · this assignee

33
3D Lighting… · lowest

7

What this shows Glaxosmithkline's Innovation Score is 33.5/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glaxosmithkline?

Each dot is one of Glaxosmithkline’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glaxosmithkline’s own 8.6 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Glaxosmithkline vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glaxosmithkline's grants concentrate

Glaxosmithkline Consumer Healthcare (UK) IP Limited is a focused PatentsView assignee: 14 CPC subclasses with 36.4% of grants classified under A46B (Brushes). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2024. By volume, Glaxosmithkline sits between Gapwaves AB and General Fusion Inc..

Glaxosmithkline's three-year grant acceleration

Glaxosmithkline Consumer Healthcare (UK) IP Limited shows 7 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gapwaves AB

22
GCI Outdoor

22
Gessi S P A

22
GIL Medical Center

22
GPB Scientific

22
Gpsip

22
Galera Labs

22
General Fusion

22
Glaxosmithkline C… ◀

22

What this shows Glaxosmithkline holds 22 patents at rank #13,439, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Glaxosmithkline

By rank, the assignees closest to #13,439 in granted patent volume.

Leaders in A46B (Brushes)

Other assignees with the most granted patents in Glaxosmithkline's primary technology class.

Glaxosmithkline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Glaxosmithkline Consumer Healthcare (UK) IP Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	9.1%
2018	2	9.1%
2019	2	9.1%
2020	2	9.1%
2021	7	31.8%
2022	2	9.1%
2023	4	18.2%
2024	1	4.5%

Which technologies does Glaxosmithkline Consumer Healthcare (UK) IP Limited patent most?

A46B - Brushes 8

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 7

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

G07F - Coin-freed OR Like Apparatus 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

F16H - Gearing 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

A46D - Manufacture OF Brushes 1

F16D - Couplings FOR Transmitting ROTATION; CLUTCHES; Brakes 1

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Glaxosmithkline Consumer Healthcare (UK) IP Limited's patent record in context - here's where to go next.

Glaxosmithkline Consumer Healthcare (UK) IP Limited's lead technology class is A46B (Brushes), 36.4% of its portfolio - see every assignee active in that class. Explore A46B
Ranked #13,446 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Glaxosmithkline Consumer Healthcare (UK) IP Limited against Gapwaves AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.